Arcadia Biosciences Inc (NASDAQ:RKDA) — Market Cap & Net Worth
Market Cap & Net Worth: Arcadia Biosciences Inc (RKDA)
Arcadia Biosciences Inc (NASDAQ:RKDA) has a market capitalization of $1.72 Million ($1.72 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30107 globally and #6051 in its home market, demonstrating a -9.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Arcadia Biosciences Inc's stock price $0.84 by its total outstanding shares 2056884 (2.06 Million). Review RKDA total debt and obligations to assess the company's total debt and financial obligations.
Arcadia Biosciences Inc Market Cap History: 2015 to 2026
Arcadia Biosciences Inc's market capitalization history from 2015 to 2026. Data shows change from $5.00 Billion to $1.72 Million (-52.45% CAGR).
Index Memberships
Arcadia Biosciences Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2834 of 3165 |
Weight: Arcadia Biosciences Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Arcadia Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Arcadia Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.84x
Arcadia Biosciences Inc's market cap is 0.84 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.51 Billion | $3.19 Million | -$19.62 Million | 474.86x | N/A |
| 2017 | $452.51 Million | $4.03 Million | -$15.71 Million | 112.40x | N/A |
| 2018 | $260.81 Million | $1.46 Million | -$13.48 Million | 178.15x | N/A |
| 2019 | $450.87 Million | $1.17 Million | -$28.80 Million | 385.69x | N/A |
| 2020 | $208.16 Million | $8.03 Million | -$4.66 Million | 25.91x | N/A |
| 2021 | $85.57 Million | $6.78 Million | -$14.66 Million | 12.62x | N/A |
| 2022 | $22.30 Million | $7.42 Million | -$15.38 Million | 3.01x | N/A |
| 2023 | $6.44 Million | $4.45 Million | -$13.98 Million | 1.45x | N/A |
| 2024 | $12.18 Million | $5.04 Million | -$7.04 Million | 2.41x | N/A |
| 2025 | $4.07 Million | $4.86 Million | -$2.34 Million | 0.84x | N/A |
Competitor Companies of RKDA by Market Capitalization
Companies near Arcadia Biosciences Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Arcadia Biosciences Inc by market ranking:
- Nestlé S.A (F:NESM): Ranked #87 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #98 globally with a market cap of $204.31 Billion USD ( CHF161.60 Billion CHF).
- Danone SA (PA:BN): Ranked #550 globally with a market cap of $49.54 Billion USD ( €42.37 Billion EUR).
- Danone SA (F:BSND): Ranked #704 globally with a market cap of $39.05 Billion USD ( €33.40 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Nestlé S.A | F:NESM | $224.33 Billion | €85.40 |
| #98 | Nestle S.A. | SW:NESN | $204.31 Billion | CHF79.09 |
| #550 | Danone SA | PA:BN | $49.54 Billion | €65.80 |
| #704 | Danone SA | F:BSND | $39.05 Billion | €12.80 |
Arcadia Biosciences Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Arcadia Biosciences Inc's market cap moved from $5.00 Billion to $ 1.72 Million, with a yearly change of -52.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.72 Million | -57.73% |
| 2025 | $4.07 Million | -66.55% |
| 2024 | $12.18 Million | +89.14% |
| 2023 | $6.44 Million | -71.13% |
| 2022 | $22.30 Million | -73.94% |
| 2021 | $85.57 Million | -58.89% |
| 2020 | $208.16 Million | -53.83% |
| 2019 | $450.87 Million | +72.87% |
| 2018 | $260.81 Million | -42.36% |
| 2017 | $452.51 Million | -70.11% |
| 2016 | $1.51 Billion | -69.74% |
| 2015 | $5.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Arcadia Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.72 Million USD |
| MoneyControl | $1.72 Million USD |
| MarketWatch | $1.72 Million USD |
| marketcap.company | $1.72 Million USD |
| Reuters | $1.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief,… Read more